PHARMA
PHARMAPharmaceutical Hydrogenation Membrane in Belgium
Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. Belgium plays a strategic role in Europe's hydrogen landscape, both as a technology hub and transit corridor.
Market Context
BelgiumPolicy
H₂ Target
Cities
Industries
Ultra-Clean Hydrogen Source
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
GMP-Compatible On-Site Generation
On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.
Batch-Flexible Operation
Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.
Pharmaceutical Hydrogenation in Belgium’s Hydrogen Market
Belgium plays a strategic role in Europe's hydrogen landscape, both as a technology hub and transit corridor. The port of Antwerp is a major chemical and refining cluster with significant hydrogen demand. Belgium is also home to Zirfon manufacturing, making it a natural market for demonstrating IONZERA's superior performance credentials.
In Zirfon's home market, IONZERA offers a compelling technical alternative with 3x lower area resistance. Belgian electrolyser developers and research institutions can directly benchmark IONZERA against the incumbent, validating the performance improvements in their own testing environments.
Lower Resistance
Thinner Profile
PERFORMANCE ADVANTAGE
Why IONZERA for Pharmaceutical Hydrogenation in Belgium
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
Shipping & Logistics
Air freight from India in 5-7 business days. Sample quantities available for testing and qualification.
Area Resistance
3x LOWERThickness
20% THINNERPharmaceutical Hydrogenation Membrane in Belgium Cities
Frequently Asked Questions
Why choose IONZERA for pharmaceutical hydrogenation in Belgium?
IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in Belgium. In Zirfon's home market, IONZERA offers a compelling technical alternative with 3x lower area resistance.
Why consider IONZERA when Zirfon is produced locally in Belgium?
IONZERA delivers 3x lower area resistance than Zirfon PERL UTP 500, enabling significantly more efficient electrolysis. For Belgian projects prioritizing performance and competitive TCO, IONZERA provides measurable advantages even accounting for shipping from India.
Can IONZERA be tested alongside Zirfon in the same electrolyser?
Yes. IONZERA is designed as a drop-in replacement for Zirfon in standard AWE stacks. It operates in the same 30 wt% KOH electrolyte at up to 45 degrees C, enabling direct side-by-side performance comparison.
EXPLORE MORE
Request Pharmaceutical Hydrogenation Samples for Belgium
Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for Belgium-based projects.
Request Sample